Research Grade Emibetuzumab( 依玛妥珠单抗 )（CAS号：1365287-97-3）

亚型 ：IgG4-kappa

形态 ：液体

保存条件 ：-20°C

克隆性 ：单克隆

适应物种 ：Human

保质期 ：12个月

目录编号 ：DHC34201

级别 ：一抗

供应商 ：武汉益普生物科技有限公司

宿主 ：Humanized

应用范围 ：Research Grade Biosimilar

抗体英文名 ：Research Grade Emibetuzumab

抗体名 ：依玛妥珠单抗

规格 ：100ug/1mg

产品名称：Research Grade Emibetuzumab
中文名称：依玛妥珠单抗
产品货号：DHC34201
产品别名：LA480, LY-2875358
CAS号：1365287-97-3
表达系统：XtenCHO
靶点：Tyrosine-protein kinase Met, Hepatocyte growth factor receptor, Proto-oncogene c-Met, Scatter factor receptor, HGF receptor, SF receptor, HGF/SF receptor, MET
宿主种属：Humanized
反应种属：Human
亚型：IgG4-kappa
实验方法：Research Grade Biosimilar

  
 

       Aiming to develop the most reliable bioreagents, AntibodySystem SAS was founded in 2019 in France by a team of professionals from top industrial companies and research institutes. The collective scientific and technical experiences in our team have brought breaking throughs in multiple product developments, including recombinant antibodies, recombinant proteins, biosimilar, RUO ELISA kits and other related products. By working with talented researchers and technicians, AntibodySystem continues to upgrade product qualities and lower the overall cost, offering accountable and affordable solutions for biolabs all over the world. Since its establishment, AntibodySystem has built long term and stable collaborations with academia, pharmaceutical industry, biotech companies and research hospitals, supporting their R&D by AntibodySystem's bioreagents with excellent data accuracy and reproducibility.

       AntibodySystem由具有30多年蛋白抗体开发经验的专家创立于法国，专注于生命科学和生物制药领域研究，总部位于法国斯特拉斯堡市。AntibodySystem自主开发了高效、高产的真核重组表达系统，利用该系统生产了高质量的重组蛋白、抗体产品。目前产品包括药物靶点蛋白以及对照抗体药物、Invivo功能性抗体、SAA系列流式抗体、PEG抗体、磷酸化抗体、抗DNA抗体、抗小分子抗体、ADA抗体、PK&ADA ELISA试剂盒。

       武汉益普生物科技有限公司作为法国AntibodySystem品牌的授权经销代理商，致力于为广大科研工作者提供优质的产品服务。如果您对我们的产品感兴趣，请联系027-87638958。以上产品仅用于科研，产品信息以产品官网为准。